A consensus in the literature has converged on the idea that one's perceptions of being treated better by a leader (compared with one's coworkers' treatment by the same leader) motivate prosocial behaviour. Drawing on current theory of hubristic pride and its evolutionary role in status maintenance, we challenge this consensus by proposing that favourable, downward social comparisons of leader‐member exchange (i.e., leader‐member exchange social comparisons; LMXSC) can also lead to social undermining. Specifically, we argue that, in individuals with high trait dominance, LMXSC triggers hubristic pride, which, in turn, motivates social undermining. Results from two experiments and a longitudinal field study support this idea. In sum, our work shifts the consensus in LMXSC theory by showing when and why high LMXSC can motivate negative coworker‐directed behaviour, and it also offers practical help to organizational leaders dealing with the ethical decision of if, and when, to preferentially treat individual team members.
Rising international migration, paired with increasing public support for far-right political parties, poses a growing challenge to the countries tasked with successfully integrating immigrants into their society. Further complicating this matter is the fact that the acculturation process which immigrants undergo to fully integrate into their host society can be long, difficult, and taxing to their mental health, physical health, and sense of belonging. A better understanding of how the unique burdens faced by immigrants might be alleviated or more easily processed is therefore vital for the success of both immigrants and their host countries. Drawing on initial findings suggesting that classic psychedelics can help individuals process incidents of discrimination, make healthier decisions, and experience deeper feelings of connectedness to others, this literature review presents a roadmap for determining what classic psychedelics may offer immigrants, a large and rapidly growing international minority group.
Background and aimsAlthough large-scale population studies have linked the use of classic psychedelics (lysergic acid diethylamide, psilocybin, or mescaline) to reduced odds of physical health problems, mental health problems, and criminal behavior, the roughly 35 million adults in the United States who have used classic psychedelics are nonetheless stigmatized in the American job market. Various federal organizations in the United States automatically reject applicants on the sole basis of prior psychedelic use, thereby practicing an open form of legal discrimination against these applicants. The present study investigates whether this discrimination can be justified based on associations between lifetime classic psychedelic use and motivationally-based workplace absenteeism.MethodsUsing pooled cross-sectional data from the National Survey on Drug Use and Health (2013–2019) on 193,320 employed adults in the United States, this study tests whether lifetime classic psychedelic use predicts the number of workdays employees skipped in the last month (i.e., motivationally-based workplace absenteeism).ResultsAfter adjusting for sociodemographics, physical health indicators, and other substance use, no significant association between lifetime classic psychedelic use and motivationally-based workplace absenteeism is found.ConclusionThis study builds on classic psychedelic research that is just beginning to take work-specific outcomes into account and offers empirical justification for the elimination of arbitrary drug-based recruitment policies in the workplace.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.